GlassScriptPhysician profile
Keith A Goss
NPI 1700860715
$134,933.78
in general payments reported to CMS, 2019-2025
11 companies · $286 in 2025
The $286 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $603 · 2021: $134K · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medshape, INC. | $133,444.57 | 2021 | |
| Smith+Nephew, INC. | $770.41 | 2019-2021 | |
| Organogenesis INC. | $294.95 | 2020 | |
| Surgenex LLC | $173.26 | 2025 | Renograft, Pellograft, Surmatrix |
| Stryker Corporation | $112.73 | 2025 | Prostep Mica |
| Arbor Pharmaceuticals, INC. | $44.73 | 2020-2021 | |
| Tactile Systems Technology INC | $34.17 | 2019 | |
| Amgen INC. | $17.23 | 2020 | |
| Medtronic Minimed, INC. | $15.63 | 2020 | |
| Antares Pharma, INC. | $13.81 | 2020 | |
| Novo Nordisk INC | $12.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$189,211.02 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Goss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.